Latest Breaking News On - Jean philippe milon - Page 3 : comparemela.com

QUANTUM GENOMICS: Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing

United statesFrance generalCzech republicJean philippe milonCatherine llorens cortMike tattoryAmerican heart associationAutomatic office blood pressureDescartes universityQuantum genomics announcesPatient recruitmentEuronext growthPhilippe milonQuantum genomicsLatin americaBrain aminopeptidase

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalCzech republicJean philippe milonCatherine llorens cortMike tattorymediaAmerican heart associationAutomatic office blood pressureDescartes universityPhilippe milonQuantum genomicsLatin americaAutomatic office bloodBrain aminopeptidaseParis descartes universityEuronext growth

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalCzech republicJean philippe milonCatherine llorens cortAmerican heart associationAutomatic office blood pressureDescartes universityPhilippe milonQuantum genomicsLatin americaAutomatic office bloodBrain aminopeptidaseParis descartes universityEuronext growth

QUANTUM GENOMICS: Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs Quantum Genomics (Euronext Growth: ALQGC, OTCQX: QNNTF), a biopharmaceutical company specializing in the development

United statesFrance generalSarah merlen boulengerJean philippe milonCatherine llorens cortMike tattoryUniversity of lilleRegulatory affairsSarah merlen boulenger as head of regulatory affairsHead of regulatory affairs at quantum genomicsDescartes universityEuropean unionEuropean medicines agencyFood drug administrationQuantum genomics appoints sarah merlen boulengerEuronext growth

Quantum Genomics announces successful capital raising with a gross sum of approximately EUR 15 6 M EUR

Quantum Genomics announces successful capital raising with a gross sum of approximately €15.6 M€ Quantum Genomics has equipped itself with new financial means to pursue the development of

New yorkUnited statesFrance generalJean philippe milonCatherine llorens cortGilbert dupontPierre hesnaultGulf pharmaceutical industries julpharCompany onDescartes universityQuantum genomicsMiddle eastIndependent statesPhilippe milonNew sharesParis euronext growth